StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report report published on Friday morning. The brokerage issued a sell rating on the stock.
Ayala Pharmaceuticals Price Performance
Ayala Pharmaceuticals stock opened at $0.06 on Friday. Ayala Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $1.49. The company’s 50 day moving average price is $0.04 and its two-hundred day moving average price is $0.20. The stock has a market cap of $2.45 million, a P/E ratio of -0.01 and a beta of 1.72.
About Ayala Pharmaceuticals
Read More
- Five stocks we like better than Ayala Pharmaceuticals
- How Investors Can Find the Best Cheap Dividend Stocks
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What is a Death Cross in Stocks?
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.